Company patents
Cepheid
Cepheid's patent strategy reveals a strong, consistent focus on its core areas of Genetic & Microbiological Assays (48.6% of portfolio) and Laboratory Apparatus (43.8%), which saw significant growth in 2024 (80.0% and 55.6% YoY respectively), indicating a sustained commitment to innovation in these foundational technologies. Surprisingly, despite its core medical focus, Cepheid has shown a rapidly emerging interest in Material & Chemical Analysis, with a remarkable 120.0% YoY growth in 2025, suggesting a diversification into the underlying analytical techniques for its diagnostic platforms, while patenting in several smaller categories like Healthcare Informatics and Network Security & Access Control has declined significantly or ceased entirely by 2026 (so far).
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
105 US filings (since 2023) · 12 categories · 18 themes
Methods and compositions for identifying, quantifying, or characterizing specific biological molecules (e.g., nucleic acids, proteins, metabolites, antibodies) or microbial species, often for diagnostic, prognostic, or quality control applications.
Self-contained or modular devices designed to automate and integrate multiple steps of molecular diagnostic assays, from sample preparation to result interpretation, often for point-of-care or high-throughput applications.
Methods and reagents designed to improve the specificity, efficiency, or yield of nucleic acid capture, ligation, amplification, or library preparation steps, particularly for sequencing applications or quantitative analysis.
Miniaturized devices that manipulate small volumes of fluids (nanoliters to picoliters) through microchannels to perform laboratory functions like mixing, separation, reaction, and detection on a single chip.
Systems and components designed for precise, automated manipulation, transfer, and dispensing of liquid samples and reagents, often involving pipettes, robotic arms, and specialized sample containers.
Apparatus and methods for precisely controlling temperature profiles (heating, cooling, incubation) within laboratory reaction vessels or modules to optimize biochemical processes like gene amplification or protein assays.
Methods and kits for amplifying nucleic acids at a constant temperature, enabling faster results and point-of-care applications, often used for pathogen or contamination detection.
Identification and measurement of specific nucleic acid sequences (DNA, RNA), their expression levels, or epigenetic modifications (e.g., methylation) as indicators for disease presence, progression, risk, or treatment response.
Sophisticated software or hardware-implemented control strategies that optimize motor performance, such as precise speed/torque regulation, vibration reduction, or efficiency, often using model-based, predictive, or adaptive techniques.
Techniques for determining the rotor position, speed, or other operational parameters of an electric motor without dedicated physical sensors, often relying on back-EMF, current, or voltage measurements.
Assays leveraging CRISPR-Cas systems (e.g., Cas12, Cas13) for highly specific and sensitive detection of target nucleic acids, often involving collateral cleavage activity or reporter molecules.
Systems that integrate digital technology, sensors, or connectivity to monitor, track, or automate aspects of medication administration, often providing data feedback, personalized recommendations, or secure logging.
Development of novel motor architectures beyond traditional radial flux designs, including linear, axial, or multi-armature configurations, often to optimize for specific performance characteristics like torque density or form factor.
Containers or packaging components featuring active mechanisms for controlled release, preparation, or delivery of their contents, such as liquids, bulk materials, volatile compounds, or single-serve portions.
Systems and methods for non-invasive or minimally invasive collection and analysis of physiological data (e.g., blood pressure, electrolytes, genetic markers, B cell repertoire) to assess patient health status, screen for conditions, or aid in diagnosis.
Systems that employ imaging and image processing to automatically detect defects, verify states, or ensure quality control in manufactured goods, printed materials, or industrial processes.
Techniques for measuring, monitoring, and compensating for temperature variations within semiconductor devices, integrated circuits, or photonic components to maintain performance, prevent degradation, and ensure reliability across operating conditions.
Techniques for identifying microorganisms, assessing their viability, quantifying their presence, profiling their metabolic activity, or determining their susceptibility to antimicrobial agents, often in complex biological or environmental samples.
Patents
Showing 1-10 of 11
CRISPR-based Nucleic Acid Detection